Zhixiang Wu

机构：Shanghai Jiao Tong University, XinHua Hospital · ORCID：0000-0002-3947-2035

发表论文 58 篇 · 总被引 1013 次 · h-index 19

代表论文

• TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1 (2022 · Cell Death and Disease · 被引 128)
• PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis (2022 · Cell Death and Disease · 被引 53)
• Recent Progress in Lymphangioma (2021 · Frontiers in Pediatrics · 被引 48)
• XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor (2021 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma (2021 · BMC Cancer · 被引 27)
• Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species‑mediated apoptosis by targeting the electron transport chain (2020 · International Journal of Molecular Medicine · 被引 24)